Cai-Jun Liu

SGLT2 inhibitors and exercise in diabetic kidney disease: mechanistic rationale, emerging clinical evidence, and future perspectives

The pathophysiological mechanisms underlying DKD are summarized, the mechanistic rationale for integrating SGLT2 inhibitors with exercise is examined, and emerging experimental and clinical evidence regarding their potential effects on renal function, metabolic control, cardiovascular health, and exercise capacity is d...